SDC1 and plasma cell myeloma: 6) In a 41-year-old male patient with multiple myeloma (MM) at early relapse after BCMA-directed CAR T-cell therapy, FISH analysis on purified CD138-positive cells from a bone marrow aspirate showed high-risk disease with the detection of a 17p deletion [21].